IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
1.00
0.01 (1.01%)
At close: May 09, 2025, 3:56 PM
1.00
0.00%
After-hours: May 09, 2025, 04:00 PM EDT
1.01% (1D)
| Bid | 0.88 |
| Market Cap | 65.88M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -95.49M |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | -0.69 |
| Forward PE | -0.9 |
| Analyst | Buy |
| Ask | 1.16 |
| Volume | 67,347 |
| Avg. Volume (20D) | 158,570 |
| Open | 1.00 |
| Previous Close | 0.99 |
| Day's Range | 0.99 - 1.07 |
| 52-Week Range | 0.66 - 1.79 |
| Beta | 0.10 |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+3.22%
IO Biotech share are trading higher after announce...
Unlock content with
Pro Subscription
8 months ago
IO Biotech shares are trading lower after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.
